Explore our materials

COVID-19

Viral Infections & Inflammation Workshop 2022

Abstract 2: Clinical Rebound of COVID-19 Following Nirmatrelvir/Ritonavir Is Not Associated With Delayed Immune Response or Severe Disease - Brian Epling

Viral Infections & Inflammation Workshop 2022

Abstract 1: Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality - Joseph Rocco

Christine Bourgeois

Pharm.D., PhD

Viral Infections & Inflammation Workshop 2022

Contribution of Adipose Tissue to Chronic Inflammation - Christine Bourgeois, Pharm.D., PhD

Steven Grinspoon

Viral Infections & Inflammation Workshop 2022

Cardiovascular Issues in Acute / Chronic HIV and COVID-19 - Steven Grinspoon, MD

Avindra Nath

Viral Infections & Inflammation Workshop 2022

Neurologic Sequelae of Acute Viral Infections - Avindra Nath, MD

Mirko Paiardini

PhD

Viral Infections & Inflammation Workshop 2022

Characterizing and Targeting Acute Inflammation Following SARS-CoV-2 Infection - Mirko Paiardini, PhD

Yogen Kanthi

MD, FAHA, FSVM

Viral Infections & Inflammation Workshop 2022

Coagulopathy in Acute Viral Infections - COVID-19 - Yogen Kanthi, MD, FAHA, FSVM

Judy Lieberman

MD, PhD

Viral Infections & Inflammation Workshop 2022

Inflammasome Activation in Acute COVID-19 - Judy Lieberman, MD, PhD

DMA

Daniel M. Altmann

PhD

Viral Infections & Inflammation Workshop 2022

Post Infectious Inflammation and Long-Term Health–Across All the Infections - Daniel M. Altmann, PhD

Innovations in HIV Therapeutics 2022 - Asia-Pacific Edition

What is the Pipeline? (Drugs) - Anchalee Avihingsanon, MD, PhD

Innovations in HIV Therapeutics 2022 - Asia-Pacific Edition

Introduction: Access and Advocacy - Giten Khwairakpam